| Dr Kenneth Karl Wogensen, MD | |
|
1015 N First Avenue, Suite A, Arcadia, CA 91006-2534 | |
| (626) 566-2866 | |
| (626) 566-2850 |
| Full Name | Dr Kenneth Karl Wogensen |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 41 Years |
| Location | 1015 N First Avenue, Arcadia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932109295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | G52870 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital Of Southern Ca | Arcadia, CA | Hospital |
| Casa Colina Hospital | Pomona, CA | Hospital |
| Pomona Valley Hospital Medical Center | Pomona, CA | Hospital |
| San Antonio Regional Hospital | Upland, CA | Hospital |
| Entity Name | Kenneth K. Wogensen, Md. Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649249616 PECOS PAC ID: 5496789539 Enrollment ID: O20050919000923 |
News Archive
Genentech, a member of the Roche Group, today announced that the Phase III EMILIA study of trastuzumab emtansine (T-DM1) met its co-primary endpoint of a significant improvement in the time people with HER2-positive metastatic breast cancer (mBC) lived without their disease getting worse (progression-free survival, PFS).
A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of Clinical Pharmacology, also found a link between underuse-not taking essential medications-and an increased risk of dying or needing to be hospitalized.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
Riverain Medical announced today that the U.S. Food and Drug Administration has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity compared to the original product.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Karl Wogensen, MD 1015 N First Avenue, Suite A, Arcadia, CA 91006-2534 Ph: (626) 566-2866 | Dr Kenneth Karl Wogensen, MD 1015 N First Avenue, Suite A, Arcadia, CA 91006-2534 Ph: (626) 566-2866 |
News Archive
Genentech, a member of the Roche Group, today announced that the Phase III EMILIA study of trastuzumab emtansine (T-DM1) met its co-primary endpoint of a significant improvement in the time people with HER2-positive metastatic breast cancer (mBC) lived without their disease getting worse (progression-free survival, PFS).
A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of Clinical Pharmacology, also found a link between underuse-not taking essential medications-and an increased risk of dying or needing to be hospitalized.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
Riverain Medical announced today that the U.S. Food and Drug Administration has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity compared to the original product.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
› Verified 9 days ago
M. Lorraine Purino, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 665 W Naomi Ave, Ste. 201, Arcadia, CA 91007 Phone: 626-445-8481 Fax: 626-574-9669 | |
Mrs. Gayane Aghakhanyan, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 330 E Live Oak Ave, Arcadia, CA 91006 Phone: 626-254-1400 Fax: 626-447-4792 | |
Marita G Cristobal, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 330 E Live Oak Ave, Arcadia, CA 91006 Phone: 626-821-5858 Fax: 626-821-0858 | |
James Quines, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 330 E Live Oak Ave, Arcadia, CA 91006 Phone: 626-254-1400 | |
Dr. Linda Lanlan Wang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 330 E Live Oak Ave, Arcadia, CA 91006 Phone: 626-821-5858 Fax: 626-821-0858 | |
Dr. Vincent M Fortanasce, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 665 W Naomi Ave Ste 201, Arcadia, CA 91007 Phone: 626-445-8481 Fax: 626-574-9669 | |
Dr. John Stewart Wells, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 330 E Live Oak Ave, Arcadia, CA 91006 Phone: 626-821-5858 Fax: 626-821-0858 |